These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39271528)

  • 1. Comment on, "Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review".
    Chellapandian H; Jeyachandran S
    Neurosurg Rev; 2024 Sep; 47(1):614. PubMed ID: 39271528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review.
    Ooi SZY; Spencer RJ; Hodgson M; Mehta S; Phillips NL; Preest G; Manivannan S; Wise MP; Galea J; Zaben M
    Neurosurg Rev; 2022 Oct; 45(5):3035-3054. PubMed ID: 35790656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time course of cerebrospinal fluid inflammatory biomarkers and relationship to 6-month neurologic outcome in adult severe traumatic brain injury.
    Nwachuku EL; Puccio AM; Adeboye A; Chang YF; Kim J; Okonkwo DO
    Clin Neurol Neurosurg; 2016 Oct; 149():1-5. PubMed ID: 27450760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute phase response after fatal traumatic brain injury.
    Ondruschka B; Schuch S; Pohlers D; Franke H; Dreßler J
    Int J Legal Med; 2018 Mar; 132(2):531-539. PubMed ID: 29306988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
    Park SH; Hwang SK
    World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Clinical Outcomes 7-10 Years after Severe Traumatic Brain Injury: Exploring the Prognostic Utility of the IMPACT Lab Model and Cerebrospinal Fluid UCH-L1 and MAP-2.
    Svingos AM; Robicsek SA; Hayes RL; Wang KK; Robertson CS; Brophy GM; Papa L; Gabrielli A; Hannay HJ; Bauer RM; Heaton SC
    Neurocrit Care; 2022 Aug; 37(1):172-183. PubMed ID: 35229233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parallel Cerebrospinal Fluid and Serum Temporal Profile Assessment of Axonal Injury Biomarkers Neurofilament-Light Chain and Phosphorylated Neurofilament-Heavy Chain: Associations With Patient Outcome in Moderate-Severe Traumatic Brain Injury.
    Wang KKW; Barton DJ; McQuillan LE; Kobeissy F; Cai G; Xu H; Yang Z; Trifilio E; Williamson JB; Rubenstein R; Robertson CS; Wagner AK
    J Neurotrauma; 2024 Jul; 41(13-14):1609-1627. PubMed ID: 38588256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Biomarkers in severe traumatic brain injury: enhancing prognostic accuracy and therapeutic strategies".
    Nadeem M; Shahzad UB; Ahmed M; Khan MAF
    Neurosurg Rev; 2024 Sep; 47(1):608. PubMed ID: 39271500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing Protein Biomarkers to Detect Lethal Acute Traumatic Brain Injuries in Cerebrospinal Fluid.
    Zwirner J; Bohnert S; Franke H; Garland J; Hammer N; Möbius D; Tse R; Ondruschka B
    Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain plasticity and neuroinflammatory protein biomarkers with circulating MicroRNAs as predictors of acute brain injury outcome - A prospective cohort study.
    Sajanti A; Li Y; Hellström S; Cao Y; Girard R; Umemori J; Frantzén J; Koskimäki F; Lyne SB; Falter J; Rantamäki T; Takala R; Posti JP; Roine S; Kolehmainen S; Srinath A; Jänkälä M; Puolitaival J; Rahi M; Rinne J; Castrén E; Koskimäki J
    J Neurol Sci; 2024 Sep; 464():123169. PubMed ID: 39126731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
    Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
    J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and standardization of multiassay platforms for four commonly studied traumatic brain injury protein biomarkers: a TBI Endpoints Development Study.
    Sarkis GA; Zhu T; Yang Z; Li X; Shi Y; Rubenstein R; Yost RA; Manley GT; Wang KK
    Biomark Med; 2021 Dec; 15(18):1721-1732. PubMed ID: 34674546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of biomarkers in cerebrospinal fluid following severe traumatic brain injury: a systematic review and meta-analysis.
    Hvingelby VS; Bjarkam CR; Mathiesen TI; Poulsen FR; Bøtker MT; Husted A; Korshoej AR
    Neurosurg Rev; 2022 Aug; 45(4):2547-2564. PubMed ID: 35419643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluid proteomics of CSF and serum reveal important neuroinflammatory proteins in blood-brain barrier disruption and outcome prediction following severe traumatic brain injury: a prospective, observational study.
    Lindblad C; Pin E; Just D; Al Nimer F; Nilsson P; Bellander BM; Svensson M; Piehl F; Thelin EP
    Crit Care; 2021 Mar; 25(1):103. PubMed ID: 33712077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPACT probability of poor outcome and plasma cytokine concentrations are associated with multiple organ dysfunction syndrome following traumatic brain injury.
    Lee S; Hwang H; Yamal JM; Goodman JC; Aisiku IP; Gopinath S; Robertson CS
    J Neurosurg; 2019 Dec; 131(6):1931-1937. PubMed ID: 30641838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Levels, Temporal Trends and Clinical Associations between Biomarkers of Inflammation and Vascular Homeostasis after Pediatric Traumatic Brain Injury.
    Lele AV; Alunpipatthanachai B; Qiu Q; Clark-Bell C; Watanitanon A; Moore A; Chesnut RM; Armstead W; Vavilala MS
    Dev Neurosci; 2019; 41(3-4):177-192. PubMed ID: 31553988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute CSF interleukin-6 trajectories after TBI: associations with neuroinflammation, polytrauma, and outcome.
    Kumar RG; Diamond ML; Boles JA; Berger RP; Tisherman SA; Kochanek PM; Wagner AK
    Brain Behav Immun; 2015 Mar; 45():253-62. PubMed ID: 25555531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.
    Kellermann I; Kleindienst A; Hore N; Buchfelder M; Brandner S
    Clin Neurol Neurosurg; 2016 Jun; 145():79-83. PubMed ID: 27101088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammasome proteins as biomarkers of traumatic brain injury.
    Kerr N; Lee SW; Perez-Barcena J; Crespi C; Ibañez J; Bullock MR; Dietrich WD; Keane RW; de Rivero Vaccari JP
    PLoS One; 2018; 13(12):e0210128. PubMed ID: 30596792
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.